- Home
- FDMT vs ZTR Comparison
FDMT vs ZTR Comparison
Compare FDMT & ZTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | ZTR |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.4M | 357.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDMT | ZTR |
|---|---|---|
| Price | $7.98 | $6.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $34.29 | N/A |
| AVG Volume (30 Days) | ★ 747.3K | 219.4K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.09% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,000.00 | N/A |
| Revenue This Year | $21,227.03 | N/A |
| Revenue Next Year | $161.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 605.88 | N/A |
| 52 Week Low | $2.24 | $4.50 |
| 52 Week High | $12.34 | $6.60 |
Technical Indicators
Market Signals| Indicator | FDMT | ZTR |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 55.76 |
| Support Level | $7.30 | $6.23 |
| Resistance Level | $7.80 | $6.36 |
| Average True Range (ATR) | 0.53 | 0.05 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 55.27 | 100.00 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.